“We recognize the confusion these recent events may have caused our customers, our employees, and the public,” Emergent said in its statement. “We acknowledge that there are improvements we must make … to restore confidence in our quality systems and manufacturing processes.”
FiercePharma “FDA orders shutdown at Emergent’s troubled plant 2 weeks after handing J&J the keys” April 19, 2021
What you never want to see in the press.
Emergent needs to overcompensate to restore confidence here and hopefully are bringing in the resources on the level of consent decree mitigation.
Investigations of a Dog 
One thought on “Emergent suspends manufacturing in Baltimore”